{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:43:49Z","timestamp":1792813429439,"version":"4.5.0"},"reference-count":207,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the University of Oradea, Romania","id":[{"id":"https:\/\/ror.org\/00wzhv093","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Antimicrobials are a type of agent widely used to prevent various microbial infections in humans and animals. Antimicrobial resistance is a major cause of clinical antimicrobial therapy failure, and it has become a major public health concern around the world. Increasing the development of multiple antimicrobials has become available for humans and animals with no appropriate guidance. As a result, inappropriate use of antimicrobials has significantly produced antimicrobial resistance. However, an increasing number of infections such as sepsis are untreatable due to this antimicrobial resistance. In either case, life-saving drugs are rendered ineffective in most cases. The actual causes of antimicrobial resistance are complex and versatile. A lack of adequate health services, unoptimized use of antimicrobials in humans and animals, poor water and sanitation systems, wide gaps in access and research and development in healthcare technologies, and environmental pollution have vital impacts on antimicrobial resistance. This current review will highlight the natural history and basics of the development of antimicrobials, the relationship between antimicrobial use in humans and antimicrobial use in animals, the simplistic pathways, and mechanisms of antimicrobial resistance, and how to control the spread of this resistance.<\/jats:p>","DOI":"10.3390\/antibiotics11050667","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T13:06:23Z","timestamp":1652706383000},"page":"667","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["RETRACTED: An Overview of Antimicrobial Stewardship Optimization: The Use of Antibiotics in Humans and Animals to Prevent Resistance"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2357-283X","authenticated-orcid":false,"given":"Md.","family":"Rahman","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mst.","family":"Alam Tumpa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrukh","family":"Zehravi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy Girls Section, Prince Sattam Bin Abdul Aziz University, Alkharj 11942, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Sarker","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0810-0001","authenticated-orcid":false,"given":"Md.","family":"Yamin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9844-3632","authenticated-orcid":false,"given":"Md.","family":"Harun-Or-Rashid","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muniruddin","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarker","family":"Ramproshad","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ranada Prasad Shaha University, Narayanganj 1400, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banani","family":"Mondal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ranada Prasad Shaha University, Narayanganj 1400, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5750-0802","authenticated-orcid":false,"given":"Abhijit","family":"Dey","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, Presidency University, Kolkata 700073, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5478-8142","authenticated-orcid":false,"given":"Fouad","family":"Damiri","sequence":"additional","affiliation":[{"name":"Labortory of Biomolecules and Organic Synthesis (BioSynthO), Department of Chemistry, Faculty of Sciences Ben M\u2019Sick, University Hassan II of Casablanca, Casablanca 20000, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-2954","authenticated-orcid":false,"given":"Mohammed","family":"Berrada","sequence":"additional","affiliation":[{"name":"Labortory of Biomolecules and Organic Synthesis (BioSynthO), Department of Chemistry, Faculty of Sciences Ben M\u2019Sick, University Hassan II of Casablanca, Casablanca 20000, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6099-5693","authenticated-orcid":false,"given":"Md.","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Global Medical Science, Wonju College of Medicine, Yonsei University, Wonju 26426, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7810-8925","authenticated-orcid":false,"given":"Simona","family":"Cavalu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, P-ta 1 Decembrie 10, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fmicb.2010.00134","article-title":"A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future","volume":"1","author":"Aminov","year":"2010","journal-title":"Front. Microbiol."},{"key":"ref_2","unstructured":"World Health Organization (2012). The Evolving Threat of Antimicrobial Resistance Options for Action, World Health Organization."},{"key":"ref_3","unstructured":"World Health Organization (2014). Antimicrobial Resistance: Global Report on Surveillance, World Health Organization."},{"key":"ref_4","unstructured":"O\u2019Neill, J. (2022, March 29). Securing New Drugs for Future Generations: The Pipeline of Antibiotics. Review on Antimicrobial Resistance. Available online: https:\/\/amr-review.org\/sites\/default\/files\/SECURING%20NEW%20DRUGS%20FOR%20FUTURE%20GENERATIONS%20FINAL%20WEB_0.pdf."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Doma, A.O., Popescu, R., Mitule\u0163u, M., Muntean, D., D\u00e9gi, J., Boldea, M.V., Radulov, I., Dumitrescu, E., Muselin, F., and Puva\u010da, N. (2020). Comparative Evaluation of QnrA, QnrB, and QnrS Genes in Enterobacteriaceae Ciprofloxacin-Resistant Cases, in Swine Units and a Hospital from Western Romania. Antibiotics, 9.","DOI":"10.3390\/antibiotics9100698"},{"key":"ref_6","first-page":"33","article-title":"The importance of databases to manage the phenomenon of resistance to antimicrobials for veterinary use","volume":"9","author":"Moruzi","year":"2019","journal-title":"Environment"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Grau, S., Echeverria-Esnal, D., G\u00f3mez-Zorrilla, S., Navarrete-Rouco, M.E., Masclans, J.R., Espona, M., Gracia-Arnillas, M.P., Duran, X., Comas, M., and Horcajada, J.P. (2021). Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic. Antibiotics, 10.","DOI":"10.3390\/antibiotics10020132"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"D\u00e9gi, J., Imre, K., Herman, V., Bucur, I., Radulov, I., Petrec, O.C., and Cristina, R.T. (2021). Antimicrobial Drug-Resistant Salmonella in Urban Cats: Is There an Actual Risk to Public Health?. Antibiotics, 10.","DOI":"10.3390\/antibiotics10111404"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0065-2164(08)70573-2","article-title":"Recent Developments of Antibiotic Research and Classification of Antibiotics According to Chemical Structure","volume":"18","year":"1974","journal-title":"Adv. Appl. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fmicb.2013.00047","article-title":"The Multifaceted Roles of Antibiotics and Antibiotic Resistance in Nature","volume":"4","author":"Sengupta","year":"2013","journal-title":"Front. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.idc.2010.11.011","article-title":"Antimicrobial Stewardship","volume":"25","author":"Tamma","year":"2011","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cmi.2014.09.005","article-title":"Strategies and Challenges of Antimicrobial Stewardship in Long-Term Care Facilities","volume":"21","author":"Dyar","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cvsm.2014.11.005","article-title":"Antimicrobial Stewardship in Small Animal Veterinary Practice: From Theory to Practice Introduction: Nature of the Problem","volume":"45","author":"Guardabassi","year":"2015","journal-title":"Vet. Clin. NA Small Anim. Pract."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/03009734.2014.901445","article-title":"Antibiotic Resistance-Consequences for Animal Health, Welfare, and Food Production","volume":"119","author":"Bengtsson","year":"2014","journal-title":"Ups. J. Med. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/jac\/dkx164","article-title":"Developing a Local Antimicrobial Resistance Action Plan: The Cornwall One Health Antimicrobial Resistance Group","volume":"72","author":"Powell","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cmi.2017.08.026","article-title":"What Is Antimicrobial Stewardship?","volume":"23","author":"Dyar","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_17","unstructured":"Beyer, P. (2022, March 29). Options for a Global Development and Stewardship Framework to Combat AMR Consultation of Member States and Relevant Partners. Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/antimicrobial-resistance\/amr-gcp-irc-website\/presentations-firstconsultation-stewardshipdevelopmentframework-2017-11-9-10.pdf?sfvrsn=e5aec720_2."},{"key":"ref_18","unstructured":"Eden, C., and Ackermann, F. (2013). Making Strategy: The Journey of Strategic Management, SAGE Publications Ltd."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molstruc.2013.02.016","article-title":"Microscopic and Spectroscopic Investigation of Bioactive Glasses for Antibiotic Controlled Release","volume":"1040","author":"Cavalu","year":"2013","journal-title":"J. Mol. Struct."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/QCO.0000000000000077","article-title":"Antimicrobial Stewardship: Another Focus for Patient Safety?","volume":"27","author":"Tamma","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/00275514.1947.12017635","article-title":"What Is an Antibiotic or an Antibiotic Substance?","volume":"39","author":"Waksman","year":"1947","journal-title":"Mycologia"},{"key":"ref_22","unstructured":"American Academy of Pediatrics (2022, March 29). The History of Antibiotics\u2014HealthyChildren.Org. Available online: https:\/\/www.healthychildren.org\/."},{"key":"ref_23","unstructured":"Laskin, A.I., Bennett, J.W., and Gadd, G.M. (2003). Advances in Applied Microbiology, Elsevier."},{"key":"ref_24","unstructured":"(2022, March 29). History of Antibiotic Development. Available online: https:\/\/www.reactgroup.org\/toolbox\/understand\/antibiotics\/development-of-antibiotics-as-medicines\/."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sneader, W. (2001). History of Sulfonamides. Encycl. Life Sci., 1.","DOI":"10.1038\/npg.els.0003625"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An Overview of the Antimicrobial Resistance Mechanisms of Bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol."},{"key":"ref_27","first-page":"9","article-title":"Origins and Evolution of Antibiotic Resistance","volume":"12","author":"Davies","year":"1996","journal-title":"Microbiologia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s12276-021-00569-z","article-title":"Antibiotic Resistome from the One-Health Perspective: Understanding and Controlling Antimicrobial Resistance Transmission","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrmicro1614","article-title":"The Antibiotic Resistome: The Nexus of Chemical and Genetic Diversity","volume":"5","author":"Wright","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a New Metallo-\u03b2-Lactamase Gene, Bla NDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India","volume":"53","author":"Yong","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijmm.2013.02.009","article-title":"Intrinsic Antibiotic Resistance: Mechanisms, Origins, Challenges and Solutions","volume":"303","author":"Cox","year":"2013","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Miere, F., Vicas, S.I., Timar, A.V., Ganea, M., Zdrinca, M., Cavalu, S., Fritea, L., Vicas, L., Muresan, M., and Pallag, A. (2021). Preparation and Characterization of Two Different Liposomal Formulations with Bioactive Natural Extract for Multiple Applications. Processes, 9.","DOI":"10.3390\/pr9030432"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular Mechanisms of Antibiotic Resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"a025197","DOI":"10.1101\/cshperspect.a025197","article-title":"The Prehistory of Antibiotic Resistance","volume":"6","author":"Perry","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drup.2004.02.003","article-title":"Evolution of the Serine \u03b2-Lactamases: Past, Present and Future","volume":"7","author":"Hall","year":"2004","journal-title":"Drug Resist. Updates"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e01076-18","DOI":"10.1128\/AAC.01076-18","article-title":"Past and Present Perspectives on \u03b2-Lactamases","volume":"62","author":"Bush","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/s41564-019-0531-5","article-title":"Phylogenetic Reconciliation Reveals the Natural History of Glycopeptide Antibiotic Biosynthesis and Resistance","volume":"4","author":"Waglechner","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Bhullar, K., Waglechner, N., Pawlowski, A., Koteva, K., Banks, E.D., Johnston, M.D., Barton, H.A., and Wright, G.D. (2012). Antibiotic Resistance Is Prevalent in an Isolated Cave Microbiome. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034953"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/ismej.2008.86","article-title":"Functional Metagenomics Reveals Diverse \u03b2-Lactamases in a Remote Alaskan Soil","volume":"3","author":"Allen","year":"2009","journal-title":"ISME J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fmicb.2019.00832","article-title":"Antimicrobial Resistance Genes, Cassettes, and Plasmids Present in Salmonella Enterica Associated with United States Food Animals","volume":"10","author":"McMillan","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_41","unstructured":"(2022, March 29). About Antibiotic Resistance|Antibiotic\/Antimicrobial Resistance, Available online: https:\/\/www.cdc.gov\/drugresistance\/about.html."},{"key":"ref_42","unstructured":"(2022, March 29). World Health Organization Antibiotic Resistance. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antibiotic-resistance."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ja.2015.9","article-title":"Study of Efflux Pump Gene Expression in Rifampicin-Monoresistant Mycobacterium tuberculosis Clinical Isolates","volume":"68","author":"Li","year":"2015","journal-title":"J. Antibiot."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fmicb.2017.00178","article-title":"Rifampicin-Resistance Mutations in the RpoB Gene in Bacillus Velezensis CC09 Have Pleiotropic Effects","volume":"8","author":"Cai","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/ng.2743","article-title":"Evolution of High-Level Ethambutol-Resistant Tuberculosis through Interacting Mutations in Decaprenylphosphoryl-\u03b2-D-Arabinose Biosynthetic and Utilization Pathway Genes","volume":"45","author":"Safi","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1128\/AAC.41.8.1677","article-title":"Ethambutol Resistance in Mycobacterium tuberculosis: Critical Role of EmbB Mutations","volume":"41","author":"Sreevatsan","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"23447","DOI":"10.1074\/jbc.M113.475798","article-title":"Para-Aminosalicylic Acid Is a Prodrug Targeting Dihydrofolate Reductase in Mycobacterium tuberculosis","volume":"288","author":"Zheng","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.3548","article-title":"Genomic and Functional Analyses of Mycobacterium tuberculosis Strains Implicate Ald in D-Cycloserine Resistance","volume":"48","author":"Desjardins","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1021\/bi00892a001","article-title":"The Enzymatic Synthesis of D-Alanyl-d-Alanine. III. On the Inhibition of d-Alanyl-d-Alanine Synthetase by the Antibiotic d-Cycloserine","volume":"3","author":"Neuhaus","year":"1964","journal-title":"Biochemistry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/jb.179.16.5046-5055.1997","article-title":"Overexpression of the D-Alanine Racemase Gene Confers Resistance to D-Cycloserine in Mycobacterium Smegmatis","volume":"179","author":"Harris","year":"1997","journal-title":"J. Bacteriol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Rasmussen, G., Monecke, S., Brus, O., Ehricht, R., and S\u00f6derquist, B. (2014). Long Term Molecular Epidemiology of Methicillin-Susceptible Staphylococcus Aureus Bacteremia Isolates in Sweden. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114276"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1365-2958.2008.06365.x","article-title":"Mycothiol Biosynthesis Is Essential for Ethionamide Susceptibility in Mycobacterium tuberculosis","volume":"69","author":"Attarian","year":"2008","journal-title":"Mol. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nm0696-662","article-title":"Mutations in PncA, a Gene Encoding Pyrazinamidase\/Nicotinamidase, Cause Resistance to the Antituberculous Drug Pyrazinamide in Tubercle Bacillus","volume":"2","author":"Scorpio","year":"1996","journal-title":"Nat. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jac\/dkh070","article-title":"Antibiotic Resistance Genes, Integrons and Multiple Antibiotic Resistance in Thirty-Five Serotypes of Salmonella Enterica Isolated from Humans and Animals in the UK","volume":"53","author":"Randall","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/infdis\/173.1.196","article-title":"Characterization of the Catalase-Peroxidase Gene (KatG) and InhA Locus in Isoniazid-Resistant and -Susceptible Strains of Mycobacterium tuberculosis by Automated DNA Sequencing: Restricted Array of Mutations Associated with Drug Resistance","volume":"173","author":"Musser","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.279.5347.98","article-title":"Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis","volume":"279","author":"Rozwarski","year":"1998","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1038\/emi.2015.42","article-title":"Novel KatG Mutations Causing Isoniazid Resistance in Clinical M. Tuberculosis Isolates","volume":"4","author":"Torres","year":"2015","journal-title":"Emerg. Microbes Infect."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","article-title":"Access to Effective Antimicrobials: A Worldwide Challenge","volume":"387","author":"Laxminarayan","year":"2016","journal-title":"Lancet"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the Mechanisms and Drivers of Antimicrobial Resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2165\/00003495-200262040-00001","article-title":"Mechanisms of Antimicrobial Resistance: Their Clinical Relevance in the New Millennium","volume":"62","author":"Sefton","year":"2002","journal-title":"Drugs"},{"key":"ref_62","unstructured":"(2021, August 24). Resistance Mechanisms\u2013Antibiotic Resistance\u2013ReAct. Available online: https:\/\/www.reactgroup.org\/toolbox\/understand\/antibiotic-resistance\/resistance-mechanisms-in-bacteria\/."},{"key":"ref_63","first-page":"503","article-title":"Antibiotic Resistance-Reasons and Control Measures","volume":"9","author":"Kattupalli","year":"2019","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2165\/00003495-199958040-00002","article-title":"Antibiotic Usage in Animals. Impact on Bacterial Resistance and Public Health","volume":"58","author":"Stobberingh","year":"1999","journal-title":"Drugs"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Rahman, M.M., Rahaman, M.S., Islam, M.R., Hossain, M.E., Mithi, F.M., Ahmed, M., Sald\u00edas, M., Akkol, E.K., and Sobarzo-S\u00e1nchez, E. (2021). Multifunctional Therapeutic Potential of Phytocomplexes and Natural Extracts for Antimicrobial Properties. Antibiotics, 10.","DOI":"10.3390\/antibiotics10091076"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"20180332","DOI":"10.1098\/rspb.2018.0332","article-title":"Human, Animal and Environmental Contributors to Antibiotic Resistance in Low-Resource Settings: Integrating Behavioural, Epidemiological and One Health Approaches","volume":"285","author":"Rousham","year":"2018","journal-title":"Proc. R. Soc. B Biol. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4102\/jsava.v83i1.16","article-title":"A Survey of Antimicrobial Usage in Animals in South Africa with Specific Reference to Food Animals","volume":"83","author":"Eagar","year":"2012","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial Resistance: A Global Multifaceted Phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog. Glob. Health"},{"key":"ref_69","first-page":"1520","article-title":"Microstructure and bioactivity of acrylic bone cements for prosthetic surgery","volume":"8","author":"Cavalu","year":"2006","journal-title":"J. Optoelectron. Adv. Mater."},{"key":"ref_70","unstructured":"South African National Aids Council (2011). National Strategic Plan on HIV, STIs and TB 2012\u20132016, South African National Aids Council."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/phar.2203","article-title":"Plazomicin: A Next-Generation Aminoglycoside","volume":"39","author":"Shaeer","year":"2019","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40265-019-1054-3","article-title":"Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections","volume":"79","author":"Eljaaly","year":"2019","journal-title":"Drugs"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/jac\/dkx239","article-title":"Plazomicin Activity against Polymyxin-Resistant Enterobacteriaceae, Including MCR-1-Producing Isolates","volume":"72","author":"Poirel","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.JU.0000576820.06238.8b","article-title":"Once-Daily Plazomicin for Complicated Urinary Tract Infections","volume":"202","author":"Wagenlehner","year":"2019","journal-title":"J. Urol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e01989-17","DOI":"10.1128\/AAC.01989-17","article-title":"A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis","volume":"62","author":"Connolly","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1473-3099(18)30554-1","article-title":"Den Cefiderocol versus Imipenem-Cilastatin for the Treatment of Complicated Urinary Tract Infections Caused by Gram-Negative Uropathogens: A Phase 2, Randomised, Double-Blind, Non-Inferiority Trial","volume":"18","author":"Portsmouth","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1473-3099(16)30004-4","article-title":"Ceftazidime-Avibactam or Best Available Therapy in Patients with Ceftazidime-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Complicated Urinary Tract Infections or Complicated Intra-Abdominal Infections (REPRISE): A Randomised, Pathogen-Directed, Phase 3 Study","volume":"16","author":"Carmeli","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/cid\/ciw378","article-title":"Ceftazidime-Avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program","volume":"63","author":"Wagenlehner","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/jac\/dkw374","article-title":"Efficacy of Ceftolozane\/Tazobactam against Urinary Tract and Intra-Abdominal Infections Caused by ESBL-Producing Escherichia coli and Klebsiella pneumoniae: A Pooled Analysis of Phase 3 Clinical Trials","volume":"72","author":"Popejoy","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(14)62220-0","article-title":"Ceftolozane-Tazobactam Compared with Levofloxacin in the Treatment of Complicated Urinary-Tract Infections, Including Pyelonephritis: A Randomised, Double-Blind, Phase 3 Trial (ASPECT-CUTI)","volume":"385","author":"Wagenlehner","year":"2015","journal-title":"Lancet"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2018.0438","article-title":"Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial","volume":"319","author":"Kaye","year":"2018","journal-title":"JAMA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40121-018-0214-1","article-title":"Effect and Safety of Meropenem\u2013Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial","volume":"7","author":"Wunderink","year":"2018","journal-title":"Infect. Dis. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/cid\/ciz530","article-title":"RESTORE-IMI 1: A Multicenter, Randomized, Double-Blind Trial Comparing Efficacy and Safety of Imipenem\/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections","volume":"70","author":"Motsch","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.diagmicrobio.2017.12.013","article-title":"In Vitro Activity of Eravacycline against 2213 Gram-Negative and 2424 Gram-Positive Bacterial Pathogens Isolated in Canadian Hospital Laboratories: CANWARD Surveillance Study 2014\u20132015","volume":"91","author":"Zhanel","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkn511","article-title":"Temocillin Revived","volume":"63","author":"Livermore","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkr317","article-title":"Temocillin Use in England: Clinical and Microbiological Efficacies in Infections Caused by Extended-Spectrum and\/or Derepressed AmpC \u03b2-Lactamase-Producing Enterobacteriaceae","volume":"66","author":"Balakrishnan","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1128\/AAC.00290-09","article-title":"Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coli","volume":"53","author":"Potoski","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"105843","DOI":"10.1016\/j.ijantimicag.2019.10.024","article-title":"Activity of Temocillin against KPC-Producing Enterobacteriaceae Clinical Isolates","volume":"55","author":"Tsakris","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","article-title":"Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli","volume":"79","author":"Zhanel","year":"2019","journal-title":"Drugs"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e01801-18","DOI":"10.1128\/AAC.01801-18","article-title":"ARGONAUT-I: Activity of Cefiderocol (s-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum \u03b2-Lactamases and Carbapenemases","volume":"63","author":"Jacobs","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"106128","DOI":"10.1016\/j.ijantimicag.2020.106128","article-title":"In Vitro Activity of Cefiderocol against Aerobic Gram-Negative Bacterial Pathogens from Germany","volume":"56","author":"Kresken","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijantimicag.2017.06.014","article-title":"Activity of Temocillin against CTX-M-Producing Escherichia coli and Klebsiella pneumoniae from Germany","volume":"51","author":"Kresken","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1473-3099(20)30731-3","article-title":"Cefiderocol versus High-Dose, Extended-Infusion Meropenem for the Treatment of Gram-Negative Nosocomial Pneumonia (APEKS-NP): A Randomised, Double-Blind, Phase 3, Non-Inferiority Trial","volume":"21","author":"Wunderink","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40265-017-0851-9","article-title":"Imipenem\u2013Relebactam and Meropenem\u2013Vaborbactam: Two Novel Carbapenem-\u03b2-Lactamase Inhibitor Combinations","volume":"78","author":"Zhanel","year":"2017","journal-title":"Drugs"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e00465-17","DOI":"10.1128\/AAC.00465-17","article-title":"Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015","volume":"61","author":"Shortridge","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"105883","DOI":"10.1016\/j.ijantimicag.2020.105883","article-title":"Der Activity of Ceftolozane-Tazobactam against Gram-Negative Pathogens Isolated from Lower Respiratory Tract Infections in the Asia-Pacific Region: SMART 2015\u20132016","volume":"55","author":"Kuo","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e01432-20","DOI":"10.1128\/AAC.01432-20","article-title":"In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems","volume":"64","author":"Karlowsky","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1128\/AAC.00830-15","article-title":"Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City","volume":"59","author":"Lapuebla","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nmni.2015.02.007","article-title":"The Global Threat of Antimicrobial Resistance: Science for Intervention","volume":"6","author":"Roca","year":"2015","journal-title":"N. Microbes N. Infect."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1515\/pac-2018-0707","article-title":"Combating Bacterial Resistance by Combination of Antibiotics with Antimicrobial Peptides","volume":"91","author":"Sheard","year":"2019","journal-title":"Pure Appl. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.fsi.2020.12.005","article-title":"Cerocin, a Novel Piscidin-like Antimicrobial Peptide from Black Seabass, Centropristis Striata","volume":"110","author":"Qiao","year":"2021","journal-title":"Fish Shellfish Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e3294","DOI":"10.1002\/psc.3294","article-title":"Multiple Action Mechanism and in Vivo Antimicrobial Efficacy of Antimicrobial Peptide Jelleine-I","volume":"27","author":"Jia","year":"2021","journal-title":"J. Pept. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10493-020-00584-1","article-title":"A Novel Defensin-like Peptide Contributing to Antimicrobial and Antioxidant Capacity of the Tick Dermacentor silvarum (Acari: Ixodidae)","volume":"83","author":"Li","year":"2021","journal-title":"Exp. Appl. Acarol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jff.2018.11.028","article-title":"Applications of New Functions for Inducing Host Defense Peptides and Synergy Sterilization of Medium Chain Fatty Acids in Substituting In-Feed Antibiotics","volume":"52","author":"Zhou","year":"2019","journal-title":"J. Funct. Foods"},{"key":"ref_105","first-page":"5","article-title":"Open Access Bioequivalence & Bioavailability Prevalence and Consequences of Misuse of Antibiotics, Survey Based Study in Karachi","volume":"7","author":"Qamar","year":"2015","journal-title":"Karachi Artic. J. Bioequiv. Bioavailab."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31254\/jsir.2014.3204","article-title":"Nat Ional Treat Ment Guidelines for Ant Imicrobial Use in Infect Ious Diseases NAT IONAL CENT RE FOR DI\u2026 Correspondence: Use of 3rd Generation Cephalosporins in Different Age Groups in Tertiary Health Care Centers of Karachi","volume":"3","author":"Naveed","year":"2014","journal-title":"J. Sci. Innov. Res."},{"key":"ref_107","first-page":"1","article-title":"Analysis of Parts of Precription in Common Practice","volume":"2","author":"Hameed","year":"2016","journal-title":"Int. J. Pharm. Pract. Pharm. Sci."},{"key":"ref_108","first-page":"5","article-title":"Irrational Use of Antibiotics, in Different Age Groups of Karachi: A Wakeup Call for Antibiotic Resistance and Future Infections Formulation and Evaluation of Fast Dissolving Tablets (ODTs) of Etoricoxib by DC View Project Cyberchondria, A Peril in Our Soc","volume":"8","author":"Hameed","year":"2016","journal-title":"Artic. J. Bioequiv. Bioavailab."},{"key":"ref_109","unstructured":"World Health Organization (2022, March 29). Global Action Plan on Antimicrobial Resistance. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241509763."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic Resistance-the Need for Global Solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/jac\/dkr541","article-title":"National Cultural Dimensions as Drivers of Inappropriate Ambulatory Care Consumption of Antibiotics in Europe and Their Relevance to Awareness Campaigns","volume":"67","author":"Borg","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(15)00520-6","article-title":"Exploring the Evidence Base for National and Regional Policy Interventions to Combat Resistance","volume":"387","author":"Dar","year":"2016","journal-title":"Lancet"},{"key":"ref_113","unstructured":"(2022, March 29). ReAct Rational Use of Antibiotics\u2013Implement the Plan. Available online: https:\/\/www.reactgroup.org\/toolbox\/policy\/implement-the-national-action-plan\/rational-use-of-antibiotics\/."},{"key":"ref_114","unstructured":"(2022, March 29). BioM\u00e9rieux Public Awareness of Antibiotic Resistance. Available online: https:\/\/amr.biomerieux.com\/en\/education\/awareness-initiatives\/."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/bmj.312.7031.613","article-title":"Growth in the Use of Antibiotics in the Community in England and Scotland in 1980\u20131993","volume":"312","author":"Davey","year":"1996","journal-title":"Br. Med. J."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0895-4356(97)00221-7","article-title":"Inappropriateness and Variability of Antibiotic Prescription among French Office-Based Physicians","volume":"51","author":"Guillemot","year":"1998","journal-title":"J. Clin. Epidemiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.317.7159.663","article-title":"Regulating the Use of Antibiotics in the Community","volume":"317","author":"Carbon","year":"1998","journal-title":"Br. Med. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/517384","article-title":"Trends in Antimicrobial Drug Use in the Community-France, 1981-1992","volume":"177","author":"Guillemot","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.279.5.365","article-title":"Low Dosage and Long Treatment Duration of \u03b2-Lactam: Risk Factors for Carriage of Penicillin-Resistant Streptococcus Pneumoniae","volume":"279","author":"Guillemot","year":"1998","journal-title":"J. Am. Med. Assoc."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0196-0644(95)70300-4","article-title":"Group A Streptococcal Tonsillopharyngitis: Cost-Effective Diagnosis and Treatment","volume":"25","author":"Pichichero","year":"1995","journal-title":"Ann. Emerg. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/infdis\/123.5.490","article-title":"Diagnosis of Streptococcal Pharyngitis: Differentiation of Active Infection from the Carrier State in the Symptomatic Child","volume":"123","author":"Kaplan","year":"1971","journal-title":"J. Infect. Dis."},{"key":"ref_122","unstructured":"Kaplan, W., and Laing, R. (2022, March 29). Priority Medicines for Europe and the World. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/68769."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/03009734.2014.902879","article-title":"The Need to Look at Antibiotic Resistance from a Health Systems Perspective","volume":"119","author":"Tomson","year":"2014","journal-title":"Upsala J. Med. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.2147\/IDR.S234610","article-title":"Antimicrobial Resistance: Implications and Costs","volume":"12","author":"Dadgostar","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_125","unstructured":"World Health Organization (2022, March 29). WHO Western Pacific. Available online: https:\/\/www.who.int\/westernpacific."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2471\/BLT.16.181743","article-title":"A Time for Action: Antimicrobial Resistance Needs Global Response","volume":"94","author":"Jinks","year":"2016","journal-title":"Bull. World Health Organ."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/milmed\/160.11.561","article-title":"Impact of Pharmacist Counseling on Medication Knowledge and Compliance","volume":"160","author":"Williford","year":"1995","journal-title":"Mil. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.3399\/bjgp13X665206","article-title":"Antibiotic Treatment of Urinary Tract Infection by Community Pharmacists: A Cross-Sectional Study","volume":"63","author":"Booth","year":"2013","journal-title":"Br. J. Gen. Pract."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11096-014-9917-x","article-title":"Effect of Clinical Pharmacist Intervention on Medication Discrepancies Following Hospital Discharge","volume":"36","author":"Farley","year":"2014","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13756-018-0351-z","article-title":"Enhancing Pharmacists\u2019 Role in Developing Countries to Overcome the Challenge of Antimicrobial Resistance: A Narrative Review","volume":"7","author":"Sakeena","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.37358\/MP.20.2.5365","article-title":"Assessment of Antibiotic Influence on Structural Modifications of Amniotic Membrane by FTIR Spectroscopy","volume":"57","author":"Roiu","year":"2020","journal-title":"Mater. Plast."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7196\/SAMJ.2016.v106i10.11468","article-title":"\u2018Esprit de Corps\u2019: Towards Collaborative Integration of Pharmacists and Nurses into Antimicrobial Stewardship Programmes in South Africa","volume":"106","author":"Schellack","year":"2016","journal-title":"S. Afr. Med. J."},{"key":"ref_133","first-page":"84","article-title":"Knowledge and Perceptions of Antimicrobial Stewardship Concepts among Final Year Pharmacy Students in Pharmacy Schools across South Africa","volume":"31","author":"Burger","year":"2016","journal-title":"S. Afr. J. Infect. Dis."},{"key":"ref_134","unstructured":"(2022, March 29). FIDSSA South African Antibiotic Stewardship Programme (SAASP). Available online: https:\/\/www.fidssa.co.za\/federation-members\/saasp-mission."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Wilkinson, A., Ebata, A., and MacGregor, H. (2018). Interventions to Reduce Antibiotic Prescribing in LMICs: A Scoping Review of Evidence from Human and Animal Health Systems. Antibiotics, 8.","DOI":"10.3390\/antibiotics8010002"},{"key":"ref_136","unstructured":"World Health Organization (2022, March 29). Using Indicators to Measure Country Pharmaceutical Situations Fact Book on WHO Level I and Level II Monitoring Indicators. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/69927\/WHO_TCM_2007.2_eng.pdf."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/viru.23706","article-title":"How to Educate Prescribers in Antimicrobial Stewardship Practices","volume":"4","author":"Pulcini","year":"2013","journal-title":"Virulence"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.280.14.1233","article-title":"Class Restriction of Cephalosporin Use to Control Total Cephalosporin Resistance in Nosocomial Klebsiella","volume":"280","author":"Rahal","year":"1998","journal-title":"JAMA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/346153","article-title":"Changes in the Prevalence of Vancomycin-Resistant Enterococci in Response to Antimicrobial Formulary Interventions: Impact of Progressive Restrictions on Use of Vancomycin and Third-Generation Cephalosporins","volume":"36","author":"Lautenbach","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/43.2.261","article-title":"The Control of Hyperendemic Glycopeptide-Resistant Enterococcus Spp. on ahaematology Unit by Changing Antibiotic Usage","volume":"43","author":"Bradley","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1345\/aph.1E236","article-title":"The Impact of New Drug Introduction on Drug Expenditure in Primary Health Care in Catalunya, Spain","volume":"39","author":"Zara","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1345\/aph.1L488","article-title":"Systematic Review of Interventions to Improve Prescribing","volume":"43","author":"Ostini","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"ref_144","unstructured":"Organisation mondiale de la Sant\u00e9 (2022, March 29). Plan D\u2019 Action Mondial Pour Combattre la R\u00e9sistance aux Antimicrobiens. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/249548\/9789242509762-fre.pdf."},{"key":"ref_145","first-page":"9","article-title":"Assessment of Clinicians Knowledge and Perception on Antimicrobial Resistance a Primary Strategy for Antimicrobial Resistance Control","volume":"15","author":"Vadivoo","year":"2015","journal-title":"Glob. J. Med. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-5908-2-26","article-title":"Applying Psychological Theories to Evidence-Based Clinical Practice: Identifying Factors Predictive of Managing Upper Respiratory Tract Infections without Antibiotics","volume":"2","author":"Eccles","year":"2007","journal-title":"Implement. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jsps.2011.11.005","article-title":"Knowledge, Attitudes and Behavior Regarding Antibiotics Use and Misuse among Adults in the Community of Jordan. A Pilot Study","volume":"20","author":"Shehadeh","year":"2012","journal-title":"Saudi Pharm. J."},{"key":"ref_148","unstructured":"Gitzinger, M. (2022, March 29). Antibiotic Resistance Response\u2014GARDP. Available online: https:\/\/gardp.org\/what-we-do\/antibiotic-resistance\/."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"De Sosa, A.J., Byarugaba, D.K., Amabile-Cuevas, C.F., Hsueh, P.R., Kariuki, S., and Okeke, I.N. (2010). Antimicrobial Resistance in Developing Countries. Antimicrobial Resistance in Developing Countries, Springer.","DOI":"10.1007\/978-0-387-89370-9"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Jairoun, A., Hassan, N., Ali, A., Jairoun, O., and Shahwan, M. (2019). Knowledge, Attitude and Practice of Antibiotic Use among University Students: A Cross Sectional Study in UAE. BMC Public Health, 19.","DOI":"10.1186\/s12889-019-6878-y"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Shahpawee, N.S., Chaw, L.L., Muharram, S.H., Goh, H.P., Hussain, Z., and Ming, L.C. (2020). University Students\u2019 Antibiotic Use and Knowledge of Antimicrobial Resistance: What Are the Common Myths?. Antibiotics, 9.","DOI":"10.20944\/preprints202005.0362.v1"},{"key":"ref_152","first-page":"20","article-title":"Antibiotic use and resistance: Perceptions and ethical challenges among doctors, pharmacists and the public in Vellore, South India","volume":"10","author":"Chandy","year":"2013","journal-title":"Indian J. Med. Ethic"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.healthpol.2008.09.002","article-title":"Factors Influencing Antibiotic Prescribing in China: An Exploratory Analysis","volume":"90","author":"Reynolds","year":"2009","journal-title":"Health Policy"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2710.2011.01293.x","article-title":"Irrational Use of Antibiotics and Role of the Pharmacist: An Insight from a Qualitative Study in New Delhi, India","volume":"37","author":"Kotwani","year":"2012","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_155","unstructured":"(2022, March 29). World Health Organization. World Health Organizations Says Being Trans Is Not A Mental Disorder|OutRight Action International. 2018. Available online: https:\/\/outrightinternational.org\/content\/world-health-organizations-says-being-trans-not-mental-disorder."},{"key":"ref_156","unstructured":"ESCMID (2022, March 29). ESCMID AMS Certificate 2022\u20132024. Available online: https:\/\/www.escmid.org\/research_projects\/study_groups\/study_groups_a_f\/antimicrobial_stewardship\/escmid_ams_certificate_2022_2024\/."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"60","DOI":"10.22159\/ijpps.2016v8i11.9827","article-title":"Patterns of Prescription and Antibiotic Use among Outpatients in a Tertiary Care Teaching Hospital of Bangladesh Pharmacokinetic Evaluation of Drug Loaded Nanoparticle in Animal Models View Project Management Strategies of ACS Syndrome in Tertiary Care Ho","volume":"8","author":"Monwar","year":"2016","journal-title":"Artic. Int. J. Pharm. Pharm. Sci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4066\/AMJ.2010.32","article-title":"Antibiotic usage at a primary health care unit in Bangladesh","volume":"3","author":"Fahad","year":"2010","journal-title":"Australas. Med. J."},{"key":"ref_159","first-page":"81","article-title":"Antimicrobial and Analgesic Activity of Leaf Extracts of Phyllanthus Reticulatus Poir. (Family-Euphorbiaceae) View Project Evaluation of Gastroprotective and Wound Healing Potential of Phyllanthus niruri L. (Euphorbiaceae) Leaves in Experimental Rats View","volume":"5","author":"Rahman","year":"2016","journal-title":"Biol. Sci."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3329\/bpj.v18i2.24318","article-title":"Survey on Antibiotic Practices in Chittagong City of Bangladesh","volume":"18","author":"Sayeed","year":"2015","journal-title":"Bangladesh Pharm. J."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Chowdhury, F., Sturm-Ramirez, K., Al Mamun, A., Iuliano, A.D., Chisti, M.J., Ahmed, M., Bhuiyan, M.U., Hossain, K., Haider, M.S., and Aziz, S.A. (2018). Effectiveness of an Educational Intervention to Improve Antibiotic Dispensing Practices for Acute Respiratory Illness among Drug Sellers in Pharmacies, a Pilot Study in Bangladesh. BMC Health Serv. Res., 18.","DOI":"10.1186\/s12913-018-3486-y"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"37","DOI":"10.22159\/ajpcr.2017.v10i8.19468","article-title":"Antimicrobial use, prescribing, and resistance in selected ten selected developing countries: A brief overview","volume":"10","author":"Haque","year":"2017","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"ref_163","first-page":"669","article-title":"Doctor\u2019s prescribing trends of antibiotics for out patients in Bangladesh: A cross-sectional health survey conducted in three districts","volume":"6","author":"Biswas","year":"2014","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.4269\/ajtmh.17-0988","article-title":"Burden and Risk Factors of Antimicrobial Use in Children Less Than 5 Years of Age with Diarrheal Illness in Rural Bangladesh","volume":"98","author":"Ahmed","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3329\/cmoshmcj.v17i2.39775","article-title":"Antibiotics Prescribing Pattern at Outpatient Department of A Tertiary Medical College Hospital","volume":"17","author":"Ata","year":"2018","journal-title":"Chattagram Maa-O-Shishu Hosp. Med. Coll. J."},{"key":"ref_166","first-page":"3964","article-title":"Prescription pattern and use of antibiotics among pediatric out patients in rajshahi city of bangladesh","volume":"9","author":"Paul","year":"2018","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"ref_167","first-page":"28","article-title":"Current Trend of Antibiotic Practice in Paediatric Surgery, Banladesh","volume":"18","author":"Shamsuddin","year":"2019","journal-title":"IOSR J. Dent. Med. Sci."},{"key":"ref_168","first-page":"405","article-title":"Indication-based use of antibiotic in the treatment of patients attending at the primary health care facility","volume":"7","author":"Hossain","year":"2018","journal-title":"Pharma Innov. J."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2147\/PPA.S140002","article-title":"Antibiotic Use for Pneumonia among Children Under-Five at a Pediatric Hospital in Dhaka City, Bangladesh","volume":"11","author":"Rashid","year":"2017","journal-title":"Patient Prefer. Adherence"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2147\/TCRM.S90110","article-title":"Intern Doctors\u2019 Views on the Current and Future Antibiotic Resistance Situation of Chattagram Maa O Shishu Hospital Medical College, Bangladesh","volume":"11","author":"Hoque","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_171","first-page":"152","article-title":"Irrational Use of Drugs, Healthcare Level and Healthcare Expenditure in Bangladesh","volume":"2","author":"Islam","year":"2017","journal-title":"Int. J. Health Econ. Policy"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3329\/bjp.v9i2.18537","article-title":"Adherence to Treatment Guidelines in a University Hospital: Exploration of Facts and Factors","volume":"9","author":"Afreen","year":"2014","journal-title":"Bangladesh J. Pharmacol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3329\/jhpn.v30i1.11289","article-title":"Availability and Rational Use of Drugs in Primary Healthcare Facilities Following the National Drug Policy of 1982: Is Bangladesh on Right Track?","volume":"30","author":"Ahmed","year":"2012","journal-title":"J. Health Popul. Nutr."},{"key":"ref_174","first-page":"1","article-title":"Antimicrobial Resistance: Bangladesh Experience","volume":"15","author":"Basher","year":"2011","journal-title":"Reg. Health Forum"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7324\/JAPS.2018.8614","article-title":"Cephalosporin-3G, Highly Prescribed Antibiotic to Outpatients in Rajshahi, Bangladesh: Prescription Errors, Carelessness, Irrational Uses Are the Triggering Causes of Antibiotic Resistance","volume":"8","author":"Chouduri","year":"2018","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.9734\/ARRB\/2014\/8184","article-title":"Irrational Use of Antibiotics and Antibiotic Resistance in Southern Rural Bangladesh: Perspectives from Both the Physicians and Patients","volume":"4","author":"Saha","year":"2014","journal-title":"Orig. Res. Artic. Annu. Res. Rev. Biol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3329\/sjps.v3i1.6799","article-title":"Patients\u2019 Knowledge and Awareness towards Use of Antibiotics in Bangladesh: A Cross-Sectional Study Conducted in Three Tertiary Healthcare Centers in Bangladesh","volume":"3","author":"Saha","year":"2010","journal-title":"Stamford J. Pharm. Sci."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Biswas, M., Roy, M.N., Manik, M.I.N., Hossain, M.S., Tapu, S.T.A., Moniruzzaman, M., and Sultana, S. (2014). Self Medicated Antibiotics in Bangladesh: A Cross-Sectional Health Survey Conducted in the Rajshahi City. BMC Public Health, 14.","DOI":"10.1186\/1471-2458-14-847"},{"key":"ref_179","first-page":"504","article-title":"Prevalence of Self-Medication of Antibiotics among People in Bangladesh","volume":"4","author":"Nishat","year":"2013","journal-title":"Indian J. Pharm. Pract."},{"key":"ref_180","first-page":"17","article-title":"Prevalence, Practice and Irrationality of Self-Medicated Antibiotics among People in Northern and Southern Region of Bangladesh","volume":"4","author":"Anwar","year":"2017","journal-title":"Int. J. Res. Pharm. Biosci."},{"key":"ref_181","first-page":"259","article-title":"Human Biology Review Original Scientific Paper","volume":"7","author":"Rana","year":"2018","journal-title":"Hum. Biol. Rev."},{"key":"ref_182","first-page":"10","article-title":"Awareness Level of Patients Regarding Usage of Antibiotics in a Slum Area of Dhaka City, Bangladesh Formulation Development View Project Hospital Pharmacy Management and Futuristic Approach with Newer Ideas View Project Awareness Level of Patients Regardi","volume":"5","author":"Saha","year":"2018","journal-title":"SSRG Int. J. Med. Sci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tcmj.2016.04.005","article-title":"Emergence of Carbapenemase-Producing Urinary Isolates at a Tertiary Care Hospital in Dhaka, Bangladesh","volume":"28","author":"Begum","year":"2016","journal-title":"Tzu Chi Med. J."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"306","DOI":"10.12980\/APJTB.4.2014C770","article-title":"A Cross Sectional Study on Antibiotic Resistance Pattern of Salmonella Typhi Clinical Isolates from Bangladesh","volume":"4","author":"Mannan","year":"2014","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3329\/bjp.v9i2.18831","article-title":"Antimicrobial Resistance and Related Issues: An Overview of Bangladesh Situation","volume":"9","author":"Rahman","year":"2014","journal-title":"Bangladesh J. Pharmacol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3329\/jdnmch.v17i1.12186","article-title":"Sensitivity Pattern of Urinary Tract Pathogens to Anti-Microbial Drugs at a Tertiary Level Hospital in Bangladesh","volume":"17","author":"Ahmed","year":"2011","journal-title":"J. Dhaka Natl. Med. Coll. Hosp."},{"key":"ref_187","first-page":"19","article-title":"A Survey on Antimicrobial Sensitivity Pattern of Different Antibiotics on Clinical Isolates of Escherichia coli Collected from Dhaka City, Bangladesh","volume":"14","author":"Shahriar","year":"2010","journal-title":"J. Appl. Sci. Environ. Manag."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3329\/jssmc.v10i2.41168","article-title":"Antimicrobial Susceptibility Pattern for Salmonella Typhi Isolated from Blood in Shaheed Suhrawardy Medical College, Dhaka","volume":"10","author":"Tarana","year":"2018","journal-title":"J. Shaheed Suhrawardy Med. Coll."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3329\/seajph.v7i2.38851","article-title":"Evaluation of Antimicrobial Resistance Pattern of Uropathogens in a Tertiary Care Hospital in Dhaka City, Bangladesh","volume":"7","author":"Nahar","year":"2017","journal-title":"South East Asia J. Public Health"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Cardos, I.A., Zaha, D.C., Sindhu, R.K., and Cavalu, S. (2021). Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies. Molecules, 26.","DOI":"10.3390\/molecules26196078"},{"key":"ref_191","first-page":"114","article-title":"The Resistance Growing Trend of Common Gram-Negative Bacteria to the Potential Antibiotics over Three Consecutive Years: A Single Center Experience in Bangladesh","volume":"7","author":"Hosen","year":"2019","journal-title":"Pharm. Pharmacol. Int. J."},{"key":"ref_192","unstructured":"(2022, March 29). Jyoti Joshi. Antibiotic Use and Resistance in Bangladesh: Situation Analysis and Recommendations-Center for Disease Dynamics, Economics & Policy (CDDEP). 2018. Available online: https:\/\/cddep.org\/publications\/bangladesh-situation-analysis-amr\/."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14202\/IJOH.2016.75-80","article-title":"Antimicrobial Residues in Tissues and Eggs of Laying Hens at Chittagong, Bangladesh","volume":"2","author":"Islam","year":"2016","journal-title":"Int. J. One Health"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"738","DOI":"10.14202\/vetworld.2014.738-743","article-title":"Antibiotic Residues in Broiler and Layer Meat in Chittagong District of Bangladesh","volume":"7","author":"Sattar","year":"2014","journal-title":"Vet. World"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3329\/ralf.v2i2.25013","article-title":"Assessment of Poultry Waste Management in Trishal Upazila, Mymensingh","volume":"2","author":"Hossen","year":"2015","journal-title":"Res. Agric. Livest. Fish."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3329\/bjz.v46i1.37629","article-title":"Oxytetracycline Residues in Thai Pangas Pangasianodon Hypophthalmus Sampled from Sylhet Sadar Upazila, Bangladesh","volume":"46","author":"Begum","year":"2018","journal-title":"Bangladesh J. Zool."},{"key":"ref_197","first-page":"55","article-title":"Assessment of Microbiological Proliferation and in Vitro Demonstration of the Antimicrobial Activity of the Commonly Available Salad Vegetables within Dhaka Metropolis","volume":"2","author":"Ahmed","year":"2014","journal-title":"Bangladesh. Am. J. Agric. For."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"e00793-17","DOI":"10.1128\/AEM.00793-17","article-title":"Environmental Spread of New Delhi Metallo-\u03b2- Lactamase-1-Producing Multidrug-Resistant Bacteria in Dhaka, Bangladesh","volume":"83","author":"Islam","year":"2017","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_199","first-page":"26712","article-title":"Antimicrobial-Resistant and ESBL-Producing Escherichia coli in Different Ecological Niches in Bangladesh","volume":"5","author":"Rashid","year":"2015","journal-title":"Infect. Ecol. Epidemiol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.17576\/jsm-2015-4403-08","article-title":"Occurrence of Antibiotic Resistant Bacteria in Pond Water Associated with Integrated Poultry-Fish Farming in Bangladesh","volume":"44","author":"Neela","year":"2015","journal-title":"Sains. Malays."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jiac.2014.07.003","article-title":"ESBL-Producing Enterobacteriaceae in Environmental Water in Dhaka, Bangladesh","volume":"20","author":"Haque","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Hoque, R., Ahmed, S.M., Naher, N., Islam, M.A., Rousham, E.K., Islam, B.Z., and Hassan, S. (2020). Tackling Antimicrobial Resistance in Bangladesh: A Scoping Review of Policy and Practice in Human, Animal and Environment Sectors. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227947"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3329\/bjvm.v15i2.35521","article-title":"A cross sectional anthropo-clinical study on antimicrobials prescription pattern in goat patients at chittagong, bangladesh","volume":"15","author":"Bhowmik","year":"2017","journal-title":"Bangladesh J. Vet. Med."},{"key":"ref_204","first-page":"1","article-title":"Fatima Mukhtar","volume":"26","author":"Hassan","year":"2019","journal-title":"Bangladesh Artic. Microbiol. Res. J. Int. March"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Huda, T., Khan, J.A.M., Ahsan, K.Z., Jamil, K., and Arifeen, S. (2014). El Monitoring and Evaluating Progress towards Universal Health Coverage in Bangladesh. PLoS Med., 11.","DOI":"10.1371\/journal.pmed.1001722"},{"key":"ref_206","unstructured":"(2022, March 29). Report of the Household Income and Expenditure Survey. Available online: http:\/\/203.112.218.65:8008\/WebTestApplication\/userfiles\/Image\/LatestReports\/HIES-10.pdf."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3329\/bjms.v20i3.52787","article-title":"Potential Strategies to Improve Antimicrobial Utilisation in Hospitals in Bangladesh Building on Experiences Across Developing Countries","volume":"20","author":"Haque","year":"2021","journal-title":"Bangladesh J. Med. Sci."}],"updated-by":[{"DOI":"10.3390\/antibiotics15020200","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000}},{"DOI":"10.3390\/antibiotics13040353","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"record-id":"69751"},{"DOI":"10.3390\/antibiotics15020200","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"record-id":"69752"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/5\/667\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:41:09Z","timestamp":1770907269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/5\/667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":207,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["antibiotics11050667"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11050667","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]}}}